| α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease R Di Maio, PJ Barrett, EK Hoffman, CW Barrett, A Zharikov, A Borah, X Hu, ... Science translational medicine 8 (342), 342ra78-342ra78, 2016 | 668 | 2016 |
| LRRK2 activation in idiopathic Parkinson’s disease R Di Maio, EK Hoffman, EM Rocha, MT Keeney, LH Sanders, ... Science translational medicine 10 (451), eaar5429, 2018 | 492 | 2018 |
| Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation RA Samarasinghe, R Di Maio, D Volonte, F Galbiati, M Lewis, G Romero, ... Proceedings of the National Academy of Sciences 108 (40), 16657-16662, 2011 | 144 | 2011 |
| Large-scale generation of human iPSC-derived neural stem cells/early neural progenitor cells and their neuronal differentiation L D’Aiuto, Y Zhi, D Kumar Das, MR Wilcox, JW Johnson, L McClain, ... Organogenesis 10 (4), 365-377, 2014 | 130 | 2014 |
| The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability E Hallacli, C Kayatekin, S Nazeen, XH Wang, Z Sheinkopf, ... Cell 185 (12), 2035-2056. e33, 2022 | 115 | 2022 |
| LRRK2 and idiopathic Parkinson’s disease EM Rocha, MT Keeney, R Di Maio, BR De Miranda, JT Greenamyre Trends in neurosciences 45 (3), 224-236, 2022 | 112 | 2022 |
| Pilocarpine alters NMDA receptor expression and function in hippocampal neurons: NADPH oxidase and ERK1/2 mechanisms R Di Maio, PG Mastroberardino, X Hu, L Montero, JT Greenamyre Neurobiology of disease 42 (3), 482-495, 2011 | 106 | 2011 |
| LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease EM Rocha, BR De Miranda, S Castro, R Drolet, NG Hatcher, L Yao, ... Neurobiology of disease 134, 104626, 2020 | 88 | 2020 |
| Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1 LMI Koharudin, H Liu, R Di Maio, RB Kodali, SH Graham, AM Gronenborn Proceedings of the National Academy of Sciences 107 (15), 6835-6840, 2010 | 87 | 2010 |
| Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults MP Horowitz, C Milanese, R Di Maio, X Hu, LM Montero, LH Sanders, ... Antioxidants & redox signaling 15 (4), 855-871, 2011 | 85 | 2011 |
| DJ-1 expression modulates astrocyte-mediated protection against neuronal oxidative stress SJ Mullett, R Di Maio, JT Greenamyre, DA Hinkle Journal of Molecular Neuroscience 49, 507-511, 2013 | 84 | 2013 |
| Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells L D'Aiuto, R Di Maio, B Heath, G Raimondi, J Milosevic, AM Watson, ... PLoS One 7 (11), e49700, 2012 | 83 | 2012 |
| Thiol oxidation and altered NR2B/NMDA receptor functions in in vitro and in vivo pilocarpine models: implications for epileptogenesis R Di Maio, PG Mastroberardino, X Hu, LM Montero, JT Greenamyre Neurobiology of disease 49, 87-98, 2013 | 62 | 2013 |
| Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats JW Lee, V Tapias, R Di Maio, JT Greenamyre, JR Cannon Neurobiology of aging 36 (1), 505-518, 2015 | 58 | 2015 |
| Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats R Di Maio, JR Cannon, JT Greenamyre Neurobiology of disease 73, 356-365, 2015 | 50 | 2015 |
| Generation of three-dimensional human neuronal cultures: application to modeling CNS viral infections L D’Aiuto, J Naciri, N Radio, S Tekur, D Clayton, G Apodaca, R Di Maio, ... Stem cell research & therapy 9, 1-9, 2018 | 47 | 2018 |
| α-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo VS Van Laar, J Chen, AD Zharikov, Q Bai, R Di Maio, AA Dukes, ... Redox biology 37, 101695, 2020 | 42 | 2020 |
| Neuronal mechanisms of epileptogenesis R Di Maio Frontiers in cellular neuroscience 8, 29, 2014 | 38 | 2014 |
| NADPH oxidase 2 activity in Parkinson's disease MT Keeney, EK Hoffman, K Farmer, CR Bodle, M Fazzari, A Zharikov, ... Neurobiology of disease 170, 105754, 2022 | 33 | 2022 |
| α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease. Sci Transl Med 8: 342ra78 R Di Maio, PJ Barrett, EK Hoffman, CW Barrett, A Zharikov, A Borah, X Hu, ... | 33 | 2016 |
J Timothy GreenamyreDirector, Pittsburgh Institute for Neurodegenerative Diseases, Professor of NeurologyΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα pitt.edu
